MX9303985A - Nucleosidos terapeuticos. - Google Patents

Nucleosidos terapeuticos.

Info

Publication number
MX9303985A
MX9303985A MX9303985A MX9303985A MX9303985A MX 9303985 A MX9303985 A MX 9303985A MX 9303985 A MX9303985 A MX 9303985A MX 9303985 A MX9303985 A MX 9303985A MX 9303985 A MX9303985 A MX 9303985A
Authority
MX
Mexico
Prior art keywords
therapeutic nucleosides
nucleosides
therapeutic
deoxy
prophylaxis
Prior art date
Application number
MX9303985A
Other languages
English (en)
Spanish (es)
Inventor
Steven Andersen Short
George Walter Koszalka
Nanine Agneta Van Draanen
George Andrew Freeman
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB929214171A external-priority patent/GB9214171D0/en
Priority claimed from GB929223180A external-priority patent/GB9223180D0/en
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of MX9303985A publication Critical patent/MX9303985A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
MX9303985A 1992-07-02 1993-07-01 Nucleosidos terapeuticos. MX9303985A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929214171A GB9214171D0 (en) 1992-07-02 1992-07-02 Therapeutic nucleosides
GB929223180A GB9223180D0 (en) 1992-11-05 1992-11-05 Therapeutic nucleosides

Publications (1)

Publication Number Publication Date
MX9303985A true MX9303985A (es) 1994-02-28

Family

ID=26301188

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9303985A MX9303985A (es) 1992-07-02 1993-07-01 Nucleosidos terapeuticos.

Country Status (9)

Country Link
EP (1) EP0648218A1 (ja)
JP (1) JPH07508531A (ja)
CN (1) CN1087089A (ja)
AU (1) AU4508593A (ja)
CA (1) CA2139132A1 (ja)
IL (1) IL106204A0 (ja)
MX (1) MX9303985A (ja)
MY (1) MY111746A (ja)
WO (1) WO1994001443A1 (ja)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997037993A1 (fr) * 1996-04-09 1997-10-16 Yamasa Corporation DERIVES DE 9-(2-DESOXY-2-FLUORO-4-THIO-β-D-ARABINOFURANOSYL)PURINE
US20030008841A1 (en) * 2000-08-30 2003-01-09 Rene Devos Anti-HCV nucleoside derivatives
KR20090089922A (ko) * 2000-10-18 2009-08-24 파마셋 인코포레이티드 바이러스 감염 및 비정상적인 세포 증식의 치료를 위한 변형된 뉴클레오시드
CN102924552B (zh) * 2012-11-14 2014-09-10 南京中医药大学 一种具有抗疱疹病毒作用的化合物
CN104497085B (zh) * 2015-01-16 2017-05-24 华东理工大学 腺苷衍生物及其用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE902574A1 (en) * 1989-07-17 1991-02-27 Univ Birmingham Antiviral pyrimidine nucleosides
ATE311399T1 (de) * 1989-09-15 2005-12-15 Southern Res Inst 2'-deoxy-4'-thioribonucleoside als antivirale und antikrebsmittel
IE74701B1 (en) * 1989-10-04 1997-07-30 Univ Birmingham Further antiviral pyrimidine nucleosides

Also Published As

Publication number Publication date
AU4508593A (en) 1994-01-31
IL106204A0 (en) 1993-11-15
JPH07508531A (ja) 1995-09-21
CA2139132A1 (en) 1994-01-20
MY111746A (en) 2000-12-30
CN1087089A (zh) 1994-05-25
WO1994001443A1 (en) 1994-01-20
EP0648218A1 (en) 1995-04-19

Similar Documents

Publication Publication Date Title
MY107843A (en) Anti-viral compounds.
MY104575A (en) Therapeutic nucleosides.
ES8801303A1 (es) Un procedimiento para preparar una formulacion farmaceutica que contiene un 2'3'-didesoxi-nucleosido.
DE69230140D1 (de) Antivirale nucleosidkombination
MY117892A (en) Therapeutic compounds
ES2150496T3 (es) Cicloalquilimidazopiridinas condensadas.
EP0349242A3 (en) Therapeutic nucleosides
CA2293470A1 (en) Benzimidazole derivatives
ES2052732T3 (es) 2',3'-didesoxi-3'-fluorotimidina y compuestos afines para el tratamiento de infecciones por adenovirus.
ATE82294T1 (de) Therapeutische nukleoside.
MX9805441A (es) Compuestos terapeuticos.
ES2130246T3 (es) Nucleosidos terapeuticos de la serie 2',3'-didesoxi-3'-fluoro-purina.
ES2052922T3 (es) Nucleosidos terapeuticos.
ATE71840T1 (de) Virushemmende nukleosidmischung.
MX9303985A (es) Nucleosidos terapeuticos.
DK0479822T3 (da) Terapeutiske nucleosider
MY106295A (en) Anti-infective nucleosides
ATE104676T1 (de) Antivirale wirkstoffe.
MX9401370A (es) Terapia antiviral.
MX9300244A (es) Derivados de difluorometilenandrostenona y proceso para su preparacion.